Among the most popular portfolio startups of the fund, we may highlight 4SC. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.
The important activity for fund was in 2000. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2011.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Deutsche Venture Capital, BioM AG, Bayern Kapital GmbH. In the next rounds fund is usually obtained by Wellington Partners, Santo Holding, Mulligan BioCapital.
Related Funds
Fund Name | Location |
Audacy Ventures | - |
Equal Ventures | New York, New York, United States |
Fisher Scientific | Houston, Texas, United States |
Israeli institutions | - |
LHV Ventures | Estonia, Harjumaa, Tallinn |
Liberty Technology Venture Capital | Colorado, Englewood, United States |
Paradigm Shift Capital | California, San Francisco, United States |
PONTIS Venture Partners Management | Austria, Vienna |
Socii Capital | California, San Francisco, United States |
Uhuru Capital | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$20M | 12 Dec 2000 | Germany, Bavaria, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$20M | 12 Dec 2000 | Germany, Bavaria, Germany |